{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:34:41Z","timestamp":1794983681439,"version":"4.9.1"},"reference-count":51,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7,27]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>SOX11 regulates MCL homing and invasion via direct regulation of CXCR4 and FAK expression and PI3K\/AKT and ERK1\/2 signaling activation. SOX11 expression increases CAM-DR, contributing to a more aggressive MCL phenotype.<\/jats:p>","DOI":"10.1182\/blood-2017-04-776740","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:40:36Z","timestamp":1495500036000},"page":"501-513","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":111,"title":["SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma"],"prefix":"10.1182","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9485-9179","authenticated-orcid":false,"given":"Patricia","family":"Balsas","sequence":"first","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC); and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2092-2526","authenticated-orcid":false,"given":"Jara","family":"Palomero","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-6762","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Eguileor","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC); and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Leonor","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3165-1768","authenticated-orcid":false,"given":"Maria Carmela","family":"Vegliante","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5948-2241","authenticated-orcid":false,"given":"Ester","family":"Planas-Rigol","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"},{"name":"Vasculitis Research Unit, Department of Autoimmune Diseases and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sureda-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4730-0938","authenticated-orcid":false,"given":"Maria C.","family":"Cid","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"},{"name":"Vasculitis Research Unit, Department of Autoimmune Diseases and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC); and"},{"name":"Department of Anatomic Pathology, Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3016-2874","authenticated-orcid":false,"given":"Virginia","family":"Amador","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC); and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111903505048900_B1","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"20","key":"2019111903505048900_B2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2019111903505048900_B3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1078-0432.CCR-13-1077","article-title":"Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry","volume":"20","author":"Espinet","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2019111903505048900_B4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","article-title":"Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis","volume":"96","author":"Ondrejka","year":"2011","journal-title":"Haematologica"},{"issue":"4","key":"2019111903505048900_B5","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"2019111903505048900_B6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.seminhematol.2011.04.001","article-title":"Molecular pathogenesis of mantle cell lymphoma: new perspectives and challenges with clinical implications","volume":"48","author":"Navarro","year":"2011","journal-title":"Semin Hematol"},{"issue":"3","key":"2019111903505048900_B7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","article-title":"Mantle cell lymphoma: a spectrum from indolent to aggressive disease","volume":"468","author":"Sander","year":"2016","journal-title":"Virchows Arch"},{"issue":"8","key":"2019111903505048900_B8","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/leu.2012.72","article-title":"Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease","volume":"26","author":"Royo","year":"2012","journal-title":"Leukemia"},{"issue":"20","key":"2019111903505048900_B9","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features","volume":"72","author":"Navarro","year":"2012","journal-title":"Cancer Res"},{"issue":"10","key":"2019111903505048900_B10","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J Clin Invest"},{"issue":"12","key":"2019111903505048900_B11","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2012-06-438937","article-title":"SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma","volume":"121","author":"Vegliante","year":"2013","journal-title":"Blood"},{"issue":"14","key":"2019111903505048900_B12","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood-2014-04-569566","article-title":"SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma","volume":"124","author":"Palomero","year":"2014","journal-title":"Blood"},{"issue":"18","key":"2019111903505048900_B13","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2012-04-424630","article-title":"Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"issue":"19","key":"2019111903505048900_B14","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2008-10-185827","article-title":"Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting","volume":"113","author":"Kurtova","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2019111903505048900_B15","doi-asserted-by":"crossref","first-page":"14350","DOI":"10.18632\/oncotarget.7320","article-title":"Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"2019111903505048900_B16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.semcancer.2011.09.006","article-title":"The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapies","volume":"21","author":"Burger","year":"2011","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"2019111903505048900_B17","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.6004\/jnccn.2014.0126","article-title":"Emerging therapy for the treatment of mantle cell lymphoma","volume":"12","author":"Rajguru","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"2019111903505048900_B18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MOH.0000000000000057","article-title":"Do mantle cell lymphomas have an \u2018Achilles heel\u2019?","volume":"21","author":"Saba","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"2019111903505048900_B19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4110\/in.2014.14.6.296","article-title":"Simultaneous inhibition of CXCR4 and VLA-4 exhibits combinatorial effect in overcoming stroma-mediated chemotherapy resistance in mantle cell lymphoma cells","volume":"14","author":"Kim","year":"2014","journal-title":"Immune Netw"},{"issue":"22","key":"2019111903505048900_B20","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood-2013-11-537555","article-title":"A phase 1 study of the PI3K\u03b4 inhibitor idelalisib in patients with relapsed\/refractory mantle cell lymphoma (MCL)","volume":"123","author":"Kahl","year":"2014","journal-title":"Blood"},{"issue":"16","key":"2019111903505048900_B21","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.18632\/oncotarget.2253","article-title":"Dual PI3K\/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma","volume":"5","author":"Rosich","year":"2014","journal-title":"Oncotarget"},{"issue":"15","key":"2019111903505048900_B22","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1101\/gad.17269211","article-title":"An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance [published correction appears in Genes Dev. 2011;25(18):1997","volume":"25","author":"Zuber","year":"2011","journal-title":"Genes Dev"},{"issue":"2","key":"2019111903505048900_B23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood-2002-04-1268","article-title":"Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells","volume":"101","author":"Kawano","year":"2003","journal-title":"Blood"},{"issue":"12","key":"2019111903505048900_B24","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1002\/ijc.28321","article-title":"Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features","volume":"133","author":"Enjuanes","year":"2013","journal-title":"Int J Cancer"},{"issue":"20","key":"2019111903505048900_B25","doi-asserted-by":"crossref","first-page":"14845","DOI":"10.1074\/jbc.M606695200","article-title":"Cellular characterization of a novel focal adhesion kinase inhibitor","volume":"282","author":"Slack-Davis","year":"2007","journal-title":"J Biol Chem"},{"issue":"9","key":"2019111903505048900_B26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Sulzmaier","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2019111903505048900_B27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/leu.2008.299","article-title":"CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers","volume":"23","author":"Burger","year":"2009","journal-title":"Leukemia"},{"issue":"16","key":"2019111903505048900_B28","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1182\/blood-2010-11-315705","article-title":"The role of phosphatidylinositol 3-kinase-\u03b4 in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111903505048900_B29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2005-05-2091","article-title":"The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status","volume":"107","author":"P\u00e9rez-Gal\u00e1n","year":"2006","journal-title":"Blood"},{"key":"2019111903505048900_B30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1478-811X-11-35","article-title":"Inhibition of a novel specific neuroglial integrin signaling pathway increases STAT3-mediated CNTF expression","volume":"11","author":"Keasey","year":"2013","journal-title":"Cell Commun Signal"},{"issue":"3","key":"2019111903505048900_B31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/path.4446","article-title":"CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival","volume":"235","author":"Moreno","year":"2015","journal-title":"J Pathol"},{"issue":"1","key":"2019111903505048900_B32","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1152\/ajpregu.00738.2001","article-title":"Chemokines and chemokine receptors in leukocyte trafficking","volume":"283","author":"Olson","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"2019111903505048900_B33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1242\/jcs.045112","article-title":"Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions","volume":"123","author":"Schaller","year":"2010","journal-title":"J Cell Sci"},{"issue":"4","key":"2019111903505048900_B34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2141.2007.06590.x","article-title":"The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target","volume":"137","author":"Burger","year":"2007","journal-title":"Br J Haematol"},{"issue":"11","key":"2019111903505048900_B35","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"issue":"5","key":"2019111903505048900_B36","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.4049\/jimmunol.174.5.2582","article-title":"CXC chemokine ligand 12-induced focal adhesion kinase activation and segregation into membrane domains is modulated by regulator of G protein signaling 1 in pro-B cells","volume":"174","author":"Le","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"2019111903505048900_B37","doi-asserted-by":"crossref","first-page":"C1339","DOI":"10.1152\/ajpcell.00144.2006","article-title":"Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways","volume":"292","author":"Huang","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"2019111903505048900_B38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jcp.21096","article-title":"Fak\/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K\/Akt-1 and MEK\/Erk pathways","volume":"212","author":"Bouchard","year":"2007","journal-title":"J Cell Physiol"},{"issue":"12","key":"2019111903505048900_B39","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1091\/mbc.12.12.4066","article-title":"Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression","volume":"12","author":"Zhao","year":"2001","journal-title":"Mol Biol Cell"},{"issue":"11","key":"2019111903505048900_B40","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3109\/10428194.2010.514968","article-title":"SOX11 expression in mantle cell lymphoma","volume":"51","author":"Xu","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2019111903505048900_B41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","article-title":"Advances in the understanding of mantle cell lymphoma","volume":"142","author":"Jares","year":"2008","journal-title":"Br J Haematol"},{"issue":"30","key":"2019111903505048900_B42","doi-asserted-by":"crossref","first-page":"48692","DOI":"10.18632\/oncotarget.8961","article-title":"Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents","volume":"7","author":"Inamdar","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"2019111903505048900_B43","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1096\/fj.14-254169","article-title":"Sox11-modified mesenchymal stem cells (MSCs) accelerate bone fracture healing: Sox11 regulates differentiation and migration of MSCs","volume":"29","author":"Xu","year":"2015","journal-title":"FASEB J"},{"issue":"1","key":"2019111903505048900_B44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal adhesion kinase: in command and control of cell motility","volume":"6","author":"Mitra","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"2019111903505048900_B45","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1096\/fj.04-3574fje","article-title":"Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells","volume":"19","author":"Segarra","year":"2005","journal-title":"FASEB J"},{"issue":"11","key":"2019111903505048900_B46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.prp.2009.07.002","article-title":"Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues","volume":"205","author":"Ozkal","year":"2009","journal-title":"Pathol Res Pract"},{"issue":"5","key":"2019111903505048900_B47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.surg.2003.10.017","article-title":"Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells","volume":"135","author":"Duxbury","year":"2004","journal-title":"Surgery"},{"issue":"18","key":"2019111903505048900_B48","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1158\/1078-0432.CCR-07-0871","article-title":"Bortezomib for the treatment of mantle cell lymphoma","volume":"13","author":"Kane","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2019111903505048900_B49","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1412096","article-title":"Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma","volume":"372","author":"Robak","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111903505048900_B50","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","article-title":"Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma","volume":"111","author":"Dal Col","year":"2008","journal-title":"Blood"},{"issue":"18","key":"2019111903505048900_B51","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1158\/1078-0432.CCR-08-3215","article-title":"Phosphatidylinositol 3\u2032-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma","volume":"15","author":"Psyrri","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/4\/501\/1404829\/blood776740.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/4\/501\/1404829\/blood776740.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T07:57:46Z","timestamp":1719215866000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/4\/501\/37096\/SOX11-promotes-tumor-protective-microenvironment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-04-776740","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}